본문 바로가기
KERD
논문KCI 등재

성조숙증 소아 대상 중재 임상시험의 등록 현황 보고 -Clinicaltrial.gov, WHO ICTPR, CRIS를 중심으로

The Current State of Registration of Interventional Clinical Trials for Children and Adolescents with Precocious Puberty

이혜림|이현희|서현식|심수보
대한한방소아과학회 (The Association of Pediatrics of Korean Medicine)|2022.08|대한한방소아과학회지 (The Journal of Pediatrics of Korean Medicine)|제36권 제3호|pp. 1-18

0

조회

0

다운로드

2

인용

0

참고문헌

키워드

Clinical trialPrecocious pubertyICTRPCRISInterventional study
주제분류한의학

초록

Objectives The purpose of this study was to investigate the current status of interventional clinical trial registration for children with precocious puberty and to secure basic data for the design of clinical trials for traditional Korean medicine treatment of precocious puberty. Methods The following resources were used to search for data: Clinicaltrial.gov, World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), and Clinical Research Information Service (CRIS), using the search terms, ‘Precocious puberty’, ‘child’. All clinical trials which were registered as of June 2022 were used. Results For the intervention and clinical trial design, gonadotropin releasing hormone (GnRH) analog was reported in 41.7% of trials, and single group assignment was performed in 66.7% of the studies. Prior consent had not been reported in 50% of the studies. Tanner stage and GnRH stimulation tests were reported by multiple trials as inclusion criteria, and prior treatment experiences for trial drugs were reported as exclusion criteria. The peak serum concentration of luteinizing hormone following GnRH stimulation test was used as a primary outcome in 45.8% of clinical trials, and other growth-related indicators such as growth rate, height, and predicted adult height were also reported. Conclusions In consideration of the design, eligibility criteria, and outcome measurement of the existing clinical trials identified in this study, it should be referred to in the design of clinical trials for traditional Korean medicine treatment of precocious puberty.

Abstract

Objectives The purpose of this study was to investigate the current status of interventional clinical trial registration for children with precocious puberty and to secure basic data for the design of clinical trials for traditional Korean medicine treatment of precocious puberty. Methods The following resources were used to search for data: Clinicaltrial.gov, World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), and Clinical Research Information Service (CRIS), using the search terms, ‘Precocious puberty’, ‘child’. All clinical trials which were registered as of June 2022 were used. Results For the intervention and clinical trial design, gonadotropin releasing hormone (GnRH) analog was reported in 41.7% of trials, and single group assignment was performed in 66.7% of the studies. Prior consent had not been reported in 50% of the studies. Tanner stage and GnRH stimulation tests were reported by multiple trials as inclusion criteria, and prior treatment experiences for trial drugs were reported as exclusion criteria. The peak serum concentration of luteinizing hormone following GnRH stimulation test was used as a primary outcome in 45.8% of clinical trials, and other growth-related indicators such as growth rate, height, and predicted adult height were also reported. Conclusions In consideration of the design, eligibility criteria, and outcome measurement of the existing clinical trials identified in this study, it should be referred to in the design of clinical trials for traditional Korean medicine treatment of precocious puberty.

참고문헌 (42)

  1. 박현영, "국내 임상연구등록시스템 구축 배경과 활성화 방안", 대한의사협회지, 54(1), pp.92~97 (2011), 대한의사협회
  2. Dickersin K, "Publication bias : the problem that won't go away", Ann N Y Acad Sci, 703, pp.135~146 (1993)
  3. Roberts R, "Pediatric drug labeling : improving the safety and efficacy of pediatric therapies", JAMA, 290(7), pp.905~911 (2003)
  4. Park SY, "Clinical trial regulation and status in US, EU, Japan and Korea for pediatric patients", Master, pp.2017
  5. Caldwell PH, "Clinical trials in children", Lancet, 364(9436), pp.803~811 (2004)
  6. 정은희, "소아에서의 약물유해반응 감시의 임상적 의의", Allergy Asthma & Respiratory Disease, 4(5), pp.309~310 (2016), 대한 소아알레르기 호흡기학회[DOI]
  7. Steinbrook R, "Testing medications in children", N Engl J Med, 347(18), pp.1462~1470 (2003)
  8. Sammons H, "Ethical issues of clinical trials in children : a European perspective", Arch Dis Child, 94(6), pp.474~477 (2009)
  9. 이유빈, "소아청소년 대상 중재연구의 등록 현황- CRIS 등록부를 중심으로 -", 대한한방소아과학회지, 33(1), pp.17~33 (2019), 대한한방소아과학회[DOI]
  10. 정희정, "국내 한방병원의 IRB 및 임상시험 실태조사", 대한한의학회지, 31(1), pp.122~129 (2010), 대한한의학회
  11. 장은하, "소아의 난치성 신증후군의 한약 치료에 대한 최신 임상연구 동향", 대한한방소아과학회지, 34(3), pp.1~17 (2020), 대한한방소아과학회[DOI]
  12. 박세미, "소아 기능성 복통의 한약치료에 대한 임상연구 동향 - 중의학 논문을 중심으로 -", 대한한방소아과학회지, 35(1), pp.104~121 (2021), 대한한방소아과학회
  13. 장진우, "소아 백반증의 한약 치료에 대한 최신 임상 연구 동향 - 중국 무작위 대조군 연구를 중심으로 -", 대한한방소아과학회지, 35(4), pp.141~155 (2021), 대한한방소아과학회
  14. 김재현, "소아 틱장애의 한약치료에 대한 최신 임상연구 동향 - 중국 무작위 대조군 임상연구를 중심으로 -", 대한한방소아과학회지, 36(1), pp.38~56 (2022), 대한한방소아과학회
  15. 정지은, "야경증의 한약 치료에 대한 임상연구 동향", 대한한방소아과학회지, 36(1), pp.78~90 (2022), 대한한방소아과학회
  16. 서희애, "성조숙증과 수면에 관한 임상연구동향", 대한한방소아과학회지, 35(4), pp.75~81 (2021), 대한한방소아과학회
  17. 김경리, "소아비만의 치료에 대한 국내 임상연구 동향", 대한한방소아과학회지, 30(3), pp.108~120 (2016), 대한한방소아과학회
  18. 허유진, "소아 구내염의 한약치료에 대한 임상연구 동향: 중의학 무작위대조군 임상시험을 중심으로", 대한한방소아과학회지, 35(4), pp.125~140 (2021), 대한한방소아과학회
  19. 권지현, "성조숙증 치료에 대한 임상 연구 동향 -최근 중의학 저널을 중심으로-", 대한한방소아과학회지, 31(1), pp.63~73 (2017), 대한한방소아과학회
  20. 이지홍, "소아 기능성 위장 장애의 한약 치료에 대한 임상연구 동향 - 중의학 무작위 대조군 임상시험을 중심으로", 대한한방소아과학회지, 35(3), pp.67~88 (2021), 대한한방소아과학회
  21. 양두화, "한방소아과학회지에 출판된 임상연구논문에 대한 분석", 대한한방소아과학회지, 32(4), pp.141~162 (2018), 대한한방소아과학회[DOI]
  22. "Statistics by ATC Codes (by In/Outpatient)" (2015)[URL]
  23. Soo Bo Shim, "Perceptions and Treatment of Precocious Puberty: A Questionnaire Survey among Caregivers in South Korea", Evidence-Based Complementary and Alternative Medicine, 2022, pp.1~10 (2022), Hindawi Limited[DOI]
  24. 이혜림, "특발성 성조숙증으로 진단받은 환아 2례에 대한 증례보고", 대한한방소아과학회지, 31(1), pp.74~81 (2017), 대한한방소아과학회
  25. Catherine DA, "Clinical trial registration : a statement from the international committee of medical journal editors", Lancet, 364(9438), pp.911~912 (2004)
  26. Lee PA, "Efficacy of leuprolide acetate 1-month depot for central precocious puberty(CPP) : growth outcomes during a prospective, longitudinal study", Int J Pediatr Endocrinol, 7, pp.1~9 (2011)
  27. Lee PA, "Efficacy and safety of leuprolide acetate 3-month depot 11.25 milligrams or 30 milligrams for the treatment of central precocious puberty", J Clin Endocrinol Metab, 97(5), pp.1572~1580 (2012)
  28. Lee PA, "36-month treatment experience of two doses of leuprolide acetate 3-month depot for children with central precocious puberty", J Clin Endocrinol Metab, 99(9), pp.3153~3159 (2014)
  29. Silverman LA, "Long-term continuous suppression with once-yearly histrelin subcutaneous implants for the treatment of central precocious puberty : a final report of a phase 3 multicenter trial", J Clin Endocrinol Metab, 100(6), pp.2354~2363 (2015)
  30. Sun W, "Effectiveness of ziyin xiehuo granules and zishen qinggan granules on partial precocious puberty in girls : a multicenter, randomized, single-blind, controlled trial", J Tradit Chin Med, 38(5), pp.740~745 (2018)
  31. Klein KO, "Phase 3 trial of a small-volume subcutaneous 6-month duration leuprolide acetate treatment for central precocious puberty", J Clin Endocrinol Metab, 105(10), pp.e3660~e3671 (2020)
  32. Luo X, "An open label, multicenter clinical trial that investigated the efficacy and safety of leuprorelin treatment of central precocious puberty in Chinese children", Medicine(Baltimore), 100(51), pp.e28158~ (2021)
  33. World Medical Association, "World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects", JAMA, 310(20), pp.2191~2194 (2013)
  34. Jeong AR LJ, "Pediatrics of korean medicine", pp.827~831 (2020), Ui Seong Dang Publishing Co
  35. "Guidelines for clinical trial evaluation in children"[URL]
  36. Dickey M, "Changing the outcomes of pediatric drug trials : APNs making a difference", J Pediatr Health Care, 27(3), pp.222~225 (2013)
  37. The Korean Society of Pediatric Endocrinology, "Clinical guidelines for precocious puberty", pp.3~5 (2011), Ui Hak Moon Hwa Sa
  38. 황진순, "성조숙증 여아에서 성선자극호르몬방출호르몬유도체 단독 치료와 성장호르몬 병합 치료가 예측성인신장에 미치는 영향", Annals of Pediatric Endocrinology & Metabolism, 12(2), pp.111~118 (2007), 대한소아내분비학회
  39. 진혜영, "진성 성조숙증에서 GnRH agonist의 용량에 따른 최종예측 성인신장 개선 효과의 차이에 관한 연구", Annals of Pediatric Endocrinology & Metabolism, 15(2), pp.120~125 (2010), 대한소아내분비학회
  40. 서지영, "진성 성조숙증으로 진단 받은 여아에서 gonadotropin-releasing hormone agonist 단독치료 및 growth hormone의 병합치료 시 예측 성인키의 변화 및 성장 획득의 비교", Clinical and Experimental Pediatrics, 49(3), pp.305~311 (2006), 대한소아청소년과학회
  41. 심계식, "중추성 성조숙증 및 조기 사춘기 여아에서 성선자극호르몬 방출호르몬작용제의 용량에 따른 사춘기 억제 효과 비교", Clinical and Experimental Pediatrics, 51(6), pp.634~639 (2008), 대한소아청소년과학회
  42. Demir A, "First morning voided urinary gonadotropin measurements as an alternative to the GnRH test", Horm Res Paediatr, 85(5), pp.301~308 (2016)

관련 논문AI추천

2022 Clinical practice guidelines for central precocious puberty of Korean children and adolescents김수진, 양아람, 이지은, Choi Jin Ho, Chung In Hyuk, Hong Yong Hee, Kang Eungu, Kim Ji Hyun, Kim Jinsup, Kim Soo Young, Lee Eun Byoul, Rhie Young-Jun, Shin Young-Lim, Yoo Eun-Gyong대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2023 · 제28권 제3호특발성 성조숙증으로 진단받은 환아 2례에 대한 증례보고박승찬, 유화승, 이혜림대한한방소아과학회 · 대한한방소아과학회지2017 · 제31권 제1호성조숙증 치료에 대한 임상 연구 동향 -최근 중의학 저널을 중심으로-권지현, 유선애, 이승연대한한방소아과학회 · 대한한방소아과학회지2017 · 제31권 제1호Effects of gonadotropin-releasing hormone agonist treatment on final adult height in boys with idiopathic central precocious pubertyCho Ah Young, Kim Eun Young, Ko Su Yeong, Lee Jae Hee대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2021 · 제26권 제4호성조숙증으로 진단된 여자 환아에서 호르몬 수치가 개선된 치험 1례이훈, 김호철, 박송이, 서경석, 이석진, 임영권, 천상렬, 허광욱대한한방소아과학회 · 대한한방소아과학회지2014 · 제28권 제4호지백지황환･대보음환 병용투여를 통한 성조숙증 치료에 대한 체계적 문헌고찰 및 메타분석강소현, 김형준, 서지혜, 이동녕, 허다희대한한방부인과학회 · 대한한방부인과학회지2021 · 제34권 제2호

이 간행물의 다른 논문 (6건)

작약, 감초 및 작약감초탕의 투여가 궤양성 대장염 동물 모델에 미치는 영향: 대사산물 변화를 포함하여박은정, 최선희pp. 19-34소아 IgA 신병증의 한약 치료에 대한 임상연구 동향정지은, 정민정pp. 35-48한의 치료를 받은 저체중 소아청소년의 특성 및 치료 효과에 대한 고찰김혜연, 김예지, 이진용, 김상민, 이선행pp. 49-62소아 주의력결핍 과잉행동장애 (ADHD)의 추나요법 효과에 대한 임상연구 고찰 – 중의학 무작위 대조군 임상연구를 중심으로 -류의성, 이민영, 김기봉, 천진홍, 최일신pp. 63-74소아 일차성 다한증의 경구 한약치료에 대한 중의학 임상연구 동향 - 중국 무작위 대조군 임상연구를 중심으로 -김기봉, 최일신, 천진홍pp. 75-86
원문 보기